Study of Comstock et al. [32] demonstrated that cytoplasmic localization of CCND1 was predominant in low-grade prostate carcinomas, whereas nuclear CCND1 was associated with high-grade tumors. This evidence concerns the gene CCND1 and prostate carcinoma.